IRLAB Announces Invitation to Presentation of the Interim Report for Q1 2022

Author's Avatar
May 04, 2022

GOTHENBURG, SWEDEN / ACCESSWIRE / May 4, 2022 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA, Financial)